Transdermal Peptide Disulfide TFA
Transdermal Peptide Disulfide TFA
收藏
¥0.00
收藏
正品保证
快速发货
  • 产品详情
  • 产品参数
  • 产品评论

产品属性:


产品名称

Transdermal Peptide Disulfide TFA

规格

1mg、5mg、10mg

货号

EY-01Y11874

Cas No.: N/A

别名: N/A

化学名: N/A

分子式: C42H65F3N14O18S2
GC61345.png
分子量: 1175.17

溶解度: H2O: 100 mg/mL (85.09 mM)

储存条件: Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.

Shipping ConditionEvaluation sample solution : ship with blue ice

All other available size: ship with RT , or blue ice upon request

产品描述:


Transdermal Peptide Disulfide TFA (TD 1 Disulfide(peptide) TFA) is a 11-amino acid peptide, binds to Na+/K+-ATPase beta-subunit (ATP1B1), and mainly interacts with the C-terminus of ATP1B1. Transdermal Peptide Disulfide TFA can enhance the transdermal delivery of many macromolecules[1].In the presence of Transdermal Peptide Disulfide, because of the specific binding of Transdermal Peptide Disulfide to ATP1B1, cells will upregulate the level of ATP1B1 to maintain function and structure; as a result, the expression of ATP1B1 increases. However, as time goes on, some Transdermal Peptide Disulfide molecules may be transported into cells by endocytosis; consequently, the expression of ATP1B1 then decreases. The interaction between Transdermal Peptide Disulfide and ATP1B1 changes not only the expression of ATP1B1, but also the localization of ATP1B1 and then the structure of the epidermal layer. This interaction can be attenuated by inhibitors or competitors, which would result in the reduced delivery of macromolecular drugs across the skin[1].[1]. Wang C, et al. Role of the Na(+)/K(+)-ATPase beta-subunit in peptide-mediated transdermal drug delivery. Mol Pharm. 2015 Apr 6;12(4):1259-67.
特别提醒公司产品仅供科研使用


英文名称
Transdermal Peptide Disulfide TFA
货号
EY-01Y11874
含量
>98.00%
规格
1mg、5mg、10mg
品牌
上海一研
首页
购物车
加入购物车
立即购买